Medicine and Dentistry
Inflammatory Arthritis
78%
Rheumatoid Arthritis
78%
Magnetic Resonance Imaging
23%
Methotrexate
18%
Disease Activity
17%
TNF Inhibitor
14%
Disease Modifying Antirheumatic Drug
14%
Glucocorticoid
11%
Cyclosporine
10%
Adalimumab
9%
Randomized Controlled Trial
9%
DAS28
9%
Betamethasone
8%
Tocilizumab
8%
Eosinophilia
8%
Arthritis
7%
Spontaneous Remission
7%
Infliximab
7%
Psoriatic Arthritis
7%
Disease-Modifying Antirheumatic Drug
7%
Osteolysis
6%
Cohort Analysis
6%
Placebo
6%
Treatment Response
5%
Anti-Citrullinated Protein Antibody
5%
Primary Health Care
5%
Synovitis
5%
Immunoglobulin M
5%
Etanercept
5%
Rheumatoid Factor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Arthritis
68%
Rheumatoid Arthritis
68%
Remission
27%
Methotrexate
17%
Adalimumab
15%
Disease Activity
15%
Tumor Necrosis Factor Inhibitor
12%
Disease Modifying Antirheumatic Drug
12%
Disease Activity Score
10%
Glucocorticoid
10%
Cohort Study
9%
Arthritis
9%
Biological Marker
8%
Infliximab
8%
Ciclosporin
6%
Biological Product
6%
Placebo
6%
Randomized Controlled Trial
6%
Tocilizumab
5%
Synovitis
5%
Monotherapy
5%
Disease
5%
Immunology and Microbiology
Inflammatory Arthritis
100%
Magnetic Resonance Imaging
17%
Synovitis
15%
Adalimumab
15%
Anti-Citrullinated Protein Antibody
14%
Methotrexate
13%
Disease-Modifying Antirheumatic Drug
12%
Immunology
12%
Rheumatoid Factor
9%
Infliximab
9%
Immunoglobulin M
8%
Arthritis
7%
TNF Inhibitor
7%
Comorbidity
7%
Galectin 3
6%
Glucocorticoid
6%
C-Reactive Protein
6%
Blood Level
5%
Tocilizumab
5%
Autoimmune Disease
5%
Osteitis
5%